Category: PAOG
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
Sandusky, OH, April 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived
PURA Schedules Update To Follow Upcoming Annual RPT Highlighting Increasing Interest In ALKM, Breaking Ground In Farmersville, And PAOG and USMJ Partnerships
Dallas, TX, April 12, 2021 – OTC PR WIRE – Puration, Inc. (OTC Pink: PURA) today announced a management update scheduled April 20th, 2021 to follow the upcoming FY2021 Annual Report coming later this week. The update will highlight PURA’s commitment to striking on an opportunity to increase its ownership in Alkame Holdings, Inc. above
PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021
Sandusky, OH, April 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is
PURA and PAOG Confirm Ongoing And Expanding Cannabis Partnership
Dallas, TX, March 11, 2021 – Puration, Inc. (OTC Pink: PURA) and PAOG Group, Inc. (OTC Pink: PAOG) today confirmed the two companies continue to work together on developing a variety of cannabis centric applications through a partnership that initiated when PAOG acquired PURA’s cannabis cultivation business last year. The PURA and
PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update
Sandusky, OH, March 10, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with
PAOG CBD RELAX-RX Co-Packing With ALKM And Marketing With USMJ Detailed In Update Scheduled Next Week
Sandusky, OH, March 9, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with North
PAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment Market
Sandusky, OH, March 8, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and depression treatment market anticipated to reach a value of $18 billion by 2025. The company recently announced plans to produce a variety of nutraceuticals
PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals
Sandusky, OH, February 18, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted the company’s anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company’s CBD nutraceutical development expansion plans. The presentation includes details on PAOG’s
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
Sandusky, OH, February 16, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today published an online, multimedia presentation detailing the company’s CBD nutraceutical development expansion plans. The CBD nutraceutical development expansion plans are anticipated to generate revenue beginning this year, in 2021 adding to the company’s previously announced anticipated revenue for
PURA Farmersville Hemp Brand Positioned To Capitalize On President Biden’s Environmental Initiative
Dallas, TX, February 12, 2020 – OTC PR WIRE – Puration, Inc. (OTC PINK: PURA) today announced publishing a multimedia presentation detailing the Company’s plans to construct a 70-acre facility designed to provide interactive, demonstrable education on the potential of hemp to provide environmentally sustainable alternatives to over $1 trillion in existing industrial products and
Recent Posts
Archives
Categories
- Aerospace
- Agriculture
- Aircraft
- Alternative Energy
- ALYI
- Apparel
- Applications
- Arts
- AUTOMOTIVE
- Autoparts
- Banking
- Barchart
- Basketball
- Beauty Products
- Beverage
- Biotechnology
- Bitcoin
- Blockchain
- Branding
- Building Material
- CANNABIS
- CBD
- Cloud
- Coffee
- Communication
- Construction
- Consumer
- Corporate
- COVID_19
- COVID-19
- Crew Management
- CRM
- Cryptocurrency
- CSE
- Digital
- Digital Currency
- ECommerce
- EDM MEDIA
- EIN Newswire
- Electric Vehicles
- Energy
- Entertainment
- Environment
- Events
- Export
- Fashion
- Featured
- Film
- Financial
- Fintech
- Fitness
- Fleet Management
- Food
- Food for thought
- Frozen Food
- Ftiness
- Fuel
- Gaming
- GEGR
- Gold
- Government
- GPS Tracking
- Healthcare
- HEMP
- ICO
- INSIDER FINANCIAL
- Insurance
- Internet
- Investingcom
- Investment
- Investor Relations
- IoT
- Jewelry
- Lifestyle
- Logistic
- Manufacturing
- Marijuana
- Marketing
- Media
- Medical
- Merger & Acquisition
- Mining
- Motorcycle
- NASDAQ
- Network
- Newsroom
- NFT
- Nutrition
- NYSE
- Oil & Gas
- Online
- OTC Markets
- OTCQB
- OTT
- PAOG
- Pet
- Pharmaceutical
- Precious Metals
- Psychedelic Mushroom
- Public Relations
- Publicity
- QMedia
- Quote
- Rare Earth
- Real Estate
- Renewable Energy
- Renovable Energy
- Rental
- Retail
- RF Components
- RLTR
- SaaS
- Science
- Security
- SFIN
- Shareholders
- Shipping
- Skincare
- Social Media
- Software
- Solar Energy
- Spirits
- Sports
- SSET
- Staffing
- Streaming
- Supplements
- Tech
- Telecommunication
- Television
- Tequila
- Transportation
- UCIX
- Uncategorized
- Video Post
- VR
- Waste Treatment
- Water Treatment
- Wellness
- Wind Power
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments